static activity of macrophages in tumour- bearing rats is decreased in the advanced stage, and that the decreased cytostatic activity of macrophages in tumour-bearing rats can be restored by local (i.p.) administration of BCG (Chikama et al., 1979) . AVe have also investigated the effect of immunopotentiators in the clinically relevant model of immunochemotherapy for advanced solid tumours (Saijo et al., 1979b) . In the present study, we first examined the optimum dose and the route and schedule of administration of BCG, focusing our attention on the systemic effect of BCG. Secondly, we examined the effect of the anticancer agent (ACNU) alone or with BCG on the cytostatic activity of macrophages. We also analysed the correlation between this cytostatic activity and the tumour growth in rats receiving immunochemotherapy.
Male Donryni strain rats weighing 120- (Saijo et al., 1978 (Saijo et al., , 1979 immunized rats rejecting > 107 viable tumour cells, whilst the minimum inoculum for growth in uinimmunized rats is 104 cells. In the experiments described here, tumours used as the source of target cells for cytostatic assay were taken 7 days after s.c. injection of 107 shown by (Giemsa stain, and by their phagocytic activity for Indian-ink particles.
To detect in vivo antitumour activity of activated peritoneal-exudate cells and macrophages, the Winn type of neutralization test was performed. Peritoneal cells were harvested from normal rats and from rats inoculated i.v. with 5 mg of BCG 21 days before by washing their peritoneal cavities. They were washed twice with MEM and finally suspended in RPMI-FCS at 2 x I06/ml. These cells were plated in the Terumo plastic dishes, and incubated for 1 h at 37°C in an atmosphere of humid 50o CO2 950 air. After nonadherent cells were removed by repeated intensive washing with MEM, macrophages adhering to the dishes were scraped with a rubber policeman and washed twice with RPMI-FCS. They were then suspended in RPMI-FCS and checked for viability. SLC cells (5 x 104/0-25 ml) and peritoneal cells or macrophages (5 x 106/ 0 25 ml) were mixed and incubated at 37°C for I h. The mixture of these cells was inoculated i.m. into the left thigh of normal Donryu strain rats, and the tumour size was measured every other day.
The cytostatic activity was determined by the modification of Germain's method Williams et al., 1975) . Flat-bottomed glass tubes (15 mm in diameter) were used for the cytostatic assay. SLC cells (2.5 x 105 cells/0 25 ml of RPMI-FCS) and 0 5 ml of RPMI-FCS were placed on the monolayer of the macrophages obtained as described above. The cytostatic activity of macrophages from normal rats was the control. The cells were incubated in 50o CO2, at 37°C for 3 h, and 0 5 tmCi of 3H-thymidine (Radiochemical Centre, Amersham, U.K.) in 0-25 ml of RPMI-FCS was added. After further incubation for 3 h, the cells were harvested on a Whatman CGF/C filter (W and R Balston Co., U.K.) and washed with 5 ml of 500 cold trichloroacetic acid 1-7 (P < 0-05); E, 16-3 + 3-4 (P < 002).
rats (Fig. 3) . In rats receiving 5 mg i.v. BCG at the time of tumour inoculation, the tumour size was 27-7 + 1P3 mm. However, the number of peritoneal cells and the cytostatic activity of macrophages returned to the normal level (Fig. 3) . In rats treated with 30 mg/kg of ACNU i.v., the tumour size decreased to 23-9 + 1-0 mm; though the number of peritoneal cells and the cytostatic activity of macrophages remained at low levels (Fig. 3) . On the other hand, in rats treated with the combination of ACNU and BCG, the tumour size decreased to 16-3 + 3-4 mm, and the number of peritoneal cells, and the cytostatic activity of macrophages,
were 20-8+7-1x 106 and 73-9+7.7/4% respectively (Fig. 3) . The vital role of macrophages in control of tumour growth and dissemination is well recognized, and many studies have reported nonspecific activation of macrophages by a variety of immunopotentiators, to become inhibitory for tumour cells in vivo and in vitro (Schultz et al., 1977) . However, there are few available data on the cytostatic activity of macrophages in rats (normal or tumour-bearing) administered systemically with anticancer agents and immunopotentiators. (Holoye et al., 1978; Sarna et al., 1978; Yamamura et al., 1979) . However, the positive role of immunochemotherapy for advanced solid tumours is still under discussion. Hosokawa et al. (1971) 
